TINAGL1 and Hepatic fibrosis: In this work, we found that knockdown of TINAGL1 by the AAV8-vector has significant preventive and therapeutic effects on liver fibrosis in mice (Figure 8-9), highlighting the potential of TINAGL1 as an innovative therapeutic target for the development of new drugs for the treatment of liver fibrosis.